K+alibre e-learning knowledge modules Module 3: Hyperkalaemia in chronic kidney failure: the role of RAAS inhibitor therapy
About the CPD course
AstraZeneca; as part of their K+alibre program; has created five online knowledge modules for healthcare professionals (HCPs) interested in learning about the causes and implications of hyperkalaemia and its treatment.
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.
Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.